S 146
Cap Insulin Prices Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Cap Insulin Prices Act aims to make insulin more affordable for patients by capping the cost-sharing for insulin under both private health insurance and Medicare. Specifically, it sets a monthly cap of $25 or 25% of the plan’s negotiated price (whichever is lower) for insulin products, beginning in 2024. The bill also modifies Medicare coverage requirements and impacts the Employee Retirement Income Security Act (ERISA) to ensure similar cost-sharing limitations for covered insulin products. This legislation seeks to address the high cost of insulin, a significant burden for many individuals with diabetes.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.